PRISM MarketView

PRISM Rare Disease Spotlight: Capricor Therapeutics Advances Treatment for Duchenne Muscular Dystrophy

New York, N.Y., February 28, 2024 - PRISM MarketView - Rare disease company, Capricor Therapeutics (Nasdaq: CAPR), has been granted an in-person Type-B meeting with the FDA to discuss chemistry, manufacturing and controls (CMC) plans for commercial launch for the potenti...

28 February 2024

PRISM Rare Disease Spotlight: Voyager Therapeutics Selects Development Candidate for Friedreich’s Ataxia, Triggers $5M Milestone Payment

New York, N.Y., February 27, 2024 - PRISM MarketView - Voyager Therapeutics (Nasdaq: VYGR) has selected a lead development candidate in its Friedreich’s Ataxia (FA) program. The company expects the program to advance into first-in-human clinical trials in 2025. Selection...

27 February 2024

AdTech and Media PRISM Index Leader PubMatic, Inc. Rises 27% On Earnings Beat

New York, N.Y., February 27, 2024 - PRISM MarketView - Digital advertising tech company PubMatic, Inc. (PUBM) has rose ~27% after announcing record earnings after the market closed on Monday. The stock is currently trading around $21/share with 1.7M shares being traded c...

27 February 2024

Charter Communications Eyes Altice in Potential Takeover Bid

New York, N.Y., February 27, 2024 - PRISM MarketView - Shares in broadband communications provider, Altice USA (NYSE: ATUS) soared on Monday following reports of a potential acquisition by Charter Communications (Nasdaq: CHTR). The news of Charter’s interest in taking ov...

27 February 2024

PRISM MarketView Launches Emerging Consumer Products Index

Emerging companies harness advanced tech to innovate, launch new products, and adapt to inflation in consumer markets

27 February 2024

SunPower Secures Over $300M in Financing to Fuel Expansion of Residential Solar and Storage Solutions

New York, February 23, 2024 - PRISM MarketView - SunPower Corp. (Nasdaq: SPWR), an emerging player in the residential solar technology and energy services sector, has successfully secured over $300 million in project financing commitments. This funding, sourced from Apol...

23 February 2024

PRISM Med Device Index Tech Company Vapotherm, Inc. (VAPO) Announces Fourth Quarter Earnings

New York, February 23, 2024 - PRISM MarketView - PRISM Emerging Med Device Index tech company Vapotherm (VAPO) specializes in the development and commercialization of innovative respiratory support devices. The company is known for its high-flow therapy systems, which de...

23 February 2024

Incannex’s CBD Chewing Gum Offers Hope for Smokers Looking to Quit

New York, February 23, 2024 - PRISM MarketView - Leading cannabinoid and psychedelic medicine company, Incannex Healthcare (Nasdaq: IXHL), has completed a pre-IND (Investigational New Drug) meeting with the FDA regarding the development of CannQuit-N for tobacco smoking ...

23 February 2024

All Charged Up: PRISM Emerging EV Index Ideal Power (IPWR) Up Over 75% in Past Five Days

New York, February 22, 2024 - PRISM MarketView - The PRISM Emerging EV tech company Ideal Power Inc. (IPWR) develops and commercializes power conversion solutions for various industries, including energy storage, renewable energy, and electric vehicles. Today the stock i...

22 February 2024

Trulieve to Open New Medical Cannabis Dispensary in Florida

New York, February 22, 2024 - PRISM MarketView - Trulieve Cannabis Corp. (Nasdaq: TCNNF) is set to expand its presence in Florida with the opening of a new medical cannabis dispensary in Pinellas Park. The dispensary, located at 6950 Park Boulevard, will cater to the gro...

22 February 2024